These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 20203227)

  • 21. Biological matrices for the evaluation of in utero exposure to drugs of abuse.
    Lozano J; García-Algar O; Vall O; de la Torre R; Scaravelli G; Pichini S
    Ther Drug Monit; 2007 Dec; 29(6):711-34. PubMed ID: 18043469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The routine analysis of breast milk for drugs of abuse in a clinical toxicology laboratory.
    Dickson PH; Lind A; Studts P; Nipper HC; Makoid M; Therkildsen D
    J Forensic Sci; 1994 Jan; 39(1):207-14. PubMed ID: 8113701
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Drug screening of newborns by meconium analysis: a large-scale, prospective, epidemiologic study.
    Ostrea EM; Brady M; Gause S; Raymundo AL; Stevens M
    Pediatrics; 1992 Jan; 89(1):107-13. PubMed ID: 1727992
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of cotinine in neonate meconium as a marker for nicotine exposure in utero.
    Sherif NA; Kamel SM; Al-Ashkar OS; Sharaki OA; Seif EA; Hegazy EA
    East Mediterr Health J; 2004; 10(1-2):96-105. PubMed ID: 16201714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Testing for drugs of abuse in meconium of newborn infants.
    Moriya F; Chan KM; Noguchi TT; Wu PY
    J Anal Toxicol; 1994; 18(1):41-5. PubMed ID: 8127083
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of cocaine exposure in the neonate. Analyses of urine, meconium, and amniotic fluid from mothers and infants exposed to cocaine.
    Casanova OQ; Lombardero N; Behnke M; Eyler FD; Conlon M; Bertholf RL
    Arch Pathol Lab Med; 1994 Oct; 118(10):988-93. PubMed ID: 7944901
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel methods for the detection of drug and alcohol exposure during pregnancy: implications for maternal and child health.
    Koren G; Hutson J; Gareri J
    Clin Pharmacol Ther; 2008 Apr; 83(4):631-4. PubMed ID: 18288086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using umbilical cord tissue to detect fetal exposure to illicit drugs: a multicentered study in Utah and New Jersey.
    Montgomery DP; Plate CA; Jones M; Jones J; Rios R; Lambert DK; Schumtz N; Wiedmeier SE; Burnett J; Ail S; Brandel D; Maichuck G; Durham CA; Henry E; Christensen RD
    J Perinatol; 2008 Nov; 28(11):750-3. PubMed ID: 18596707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of drugs of abuse detection in meconium by EMIT II and ELISA.
    Marin SJ; Keith L; Merrell M; McMillin GA
    J Anal Toxicol; 2009 Apr; 33(3):148-54. PubMed ID: 19371463
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of screening immunoassays to detect sub-threshold concentrations of cocaine, cannabinoids, and opiates in urine: use for detecting maternal and neonatal drug exposures.
    Hattab EM; Goldberger BA; Johannsen LM; Kindland PW; Ticino F; Chronister CW; Bertholf RL
    Ann Clin Lab Sci; 2000 Jan; 30(1):85-91. PubMed ID: 10678589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Meconium drug testing in multiple births in the USA.
    Wood KE; Krasowski MD; Strathmann FG; McMillin GA
    J Anal Toxicol; 2014 Sep; 38(7):397-403. PubMed ID: 24927721
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of cocaine, norcocaine, and cocaethylene in the meconium of premature neonates.
    Browne S; Moore C; Negrusz A; Tebbett I; Covert R; Dusick A
    J Forensic Sci; 1994 Nov; 39(6):1515-9. PubMed ID: 7815031
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Detection of drugs-of-abuse in meconium of a stillborn baby and in stool of a deceased 41-day-old infant.
    Moriya F; Chan KM; Noguchi TT; Parnassus WN
    J Forensic Sci; 1995 May; 40(3):505-8. PubMed ID: 7782759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug testing in the neonate.
    Cotten SW
    Clin Lab Med; 2012 Sep; 32(3):449-66. PubMed ID: 22939302
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine meconium screening versus drug screening per physician order: detecting the true incidence of drug-exposed infants.
    Zenewicz D; Kuhn PJ
    Pediatr Nurs; 1998; 24(6):543-6, 553. PubMed ID: 10085996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Opioid detection in maternal and neonatal hair and meconium: characterization of an at-risk population and implications to fetal toxicology.
    Moller M; Karaskov T; Koren G
    Ther Drug Monit; 2010 Jun; 32(3):318-23. PubMed ID: 20418801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meconium as a matrix.
    Stolk LM
    Clin Pharmacokinet; 1996 Jul; 31(1):81. PubMed ID: 8827401
    [No Abstract]   [Full Text] [Related]  

  • 38. Emerging biomarkers of intrauterine neonatal and pediatric exposures to xenobiotics.
    Delano K; Koren G
    Pediatr Clin North Am; 2012 Oct; 59(5):1059-70. PubMed ID: 23036244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ethyl linoleate in meconium: a biomarker for prenatal ethanol exposure.
    Bearer CF; Lee S; Salvator AE; Minnes S; Swick A; Yamashita T; Singer LT
    Alcohol Clin Exp Res; 1999 Mar; 23(3):487-93. PubMed ID: 10195823
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of meconium and neonatal hair analysis for detection of gestational exposure to drugs of abuse.
    Bar-Oz B; Klein J; Karaskov T; Koren G
    Arch Dis Child Fetal Neonatal Ed; 2003 Mar; 88(2):F98-F100. PubMed ID: 12598495
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.